Ожирение и метаболический синдром (Влияние на состояние здоровья, профилактика и лечение)

114. Grundy SM The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr 1999;19:325-41

115. Guezennec CY Reponses et adaptations hormonales lors d'efforts de courte duree et sous l'effet de l'entrainement. Bull Acad Natl Med 1995 Oct;179(7):1449-57; discussion 1458-9

116. Guillaume M; Lapidus L; Beckers F; Lambert A; Bjorntorp P. Familial trends of obesity through three generations: the Belgian-Luxembourg child study. Int J Obes Relat Metab Disord 1995 Sep;19 Suppl 3:S5-9

117. Gutierrez-Fisac JL; Regidor E; Rodriguez C Trends in obesity differences by educational level in Spain. J Clin Epidemiol 1996 Mar;49(3):351-4

118. Guy-Grand B. The clinical uses of dexfenfluramine in the management of obesity. /Rev. Contemp. Pharmacother. 1991 2. 2. 115-128.

119. Hakala K; Mustajoki P; Aittomaki J; Sovijarvi A Improved gas exchange during exercise after weight loss in morbid obesity. Clin Physiol 1996 May;16(3):229-38

120. Hakala P, Rissanen A, Koskenvuo M, Kaprio J, Ronnemaa T Environmental factors in the development of obesity in identical twins. Int J Obes Relat Metab Disord 1999 Jul;23(7):746-53

121. Hardie LJ; Rayner DV; Holmes S; Trayhurn P Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 1996 Jun 25;223(3):660-5

122. Hassink SG; Sheslow DV; de Lancey E; Opentanova I; Considine RV; Caro JF Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996 Aug;98(2 Pt 1):201-3

123. Helge JW, Fraser AM, Kriketos AD, Jenkins AB, Calvert GD, Ayre KJ, Storlien LH Interrelationships between muscle fibre type, substrate oxidation and body fat. Int J Obes Relat Metab Disord 1999 Sep;23(9):986-91

124. Hellerstein M. K., Christiansen M., Kaempfer S., et al., Measurement of de novo lipogenesis in humans using stable isotopes. J. Clin. Invest. 1991 87 1841-1852.

125. Henry R. R., Gumbiner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.// Diabetes Care. - 1991. - V. 14., ( 9. - P. 802-823.

126. Hernandez B, Gortmaker SL, Colditz GA, Peterson KE, Laird NM, Parra-Cabrera S Association of obesity with physical activity, television programs and other forms of video viewing among children in Mexico city. Int J Obes Relat Metab Disord 1999 Aug;23(8):845-54

127. Hernandez B; Peterson K; Sobol A; Rivera J; Sepulveda J; Lezana MA Overweight in 12-49 year-old women and children under 5 years of age in Mexico, Salud Publica Mex 1996 May-Jun;38(3):178-88

128. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999 Oct 27;282(16):1568-75

129. Hill JO, Peters JC Environmental contributions to the obesity epidemic. Science 1998 May 29;280(5368):1371-4

130. Hodge AM; Dowse GK; Gareeboo H; Tuomilehto J; Alberti KG; Zimmet PZ Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. Int J Obes Relat Metab Disord 1996 Feb;20(2):137-46

131. Hoie LH; Bruusgaard D Compliance, clinical effects, and factors predicting weight reduction during a very low calorie diet regime. Scand J Prim Health Care 1995 Mar;13(1):13-20

132. Holander P.A., Elbein S.C., Hirsch I.B. et al., Role of orlistat in the treatment of obese patients with type 2 diabetes./ Diabetes Care 1998 v21 No8 p1288-1294

133. Holst JJ [Leptin--a new way to diet?] Ugeskr Laeger 1996 Aug 5;158(32):4505-8

134. Horn-Ross P. L. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control 1995 Nov;6(6):567-73

135. Horton T. J., Drougas H., Brachey A., et al., Fat and carbohydrate overfeeding in humans: different effects on energy storage. Am. J. Clin. Nutr. 1995 62 1 19-29.

136. Howard BV Insulin resistance and lipid metabolism. Am J Cardiol 1999 Jul 8;84(1A):28J-32J

137. Husemann B. Therapie der extremen Fettsucht--Ist der Chirurg gefragt? Zentralbl Chir 1996;121(5):349-53

138. Husemann B; Reiners V Erste Ergebnisse nach vertikaler Gastroplastik zur Behandlung der extremen Adipositas. Zentralbl Chir 1996;121(5):370-5

139. Hvizdos KM, Markham A Orlistat: a review of its use in the management of obesity. Drugs 1999 Oct;58(4):743-60

140. Ikeda H; Odaka H AO-128, alpha-glucosidase inhibitor: antiobesity and antidiabetic actions in genetically obese-diabetic rats, Wistar fatty. Obes Res 1995 Nov;3 Suppl 4:617S-621S

141. Inoue S Clinical studies with mazindol. Obes Res 1995 Nov;3 Suppl 4:549S-552S

142. Kansanen M, Vanninen E, Tuunainen A, Pesonen P, Tuononen V, Hartikainen J, Mussalo H, Uusitupa M The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998 Jul;18(4):377-85